AIQ Solutions is proud to share that we have secured a sixth patent for our AI-enabled late-stage cancer analysis technology (U.S. Patent No. 12,562,258).
Our earliest patents focused on protecting the foundation of our technology – the capabilities that truly differentiate TRAQinform IQ in the market.
These latest patents represent the future of our product – innovations that lay the groundwork for what will come.
Patents aren’t just legal assets. They’re signals of where we’re going—and the impact we will make on late-stage cancer with advanced treatment response intelligence. I’m incredibly proud of the team pushing this vision forward.[GU1.1]